Linear Expression Cassettes for Cell-Free Membrane Protein Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing cell-free protein expression systems face challenges in efficiently producing and purifying membrane proteins due to the lack of generalizable methods for overexpression, aggregation issues, and the need for lengthy trials to identify suitable detergents, while cell-based systems are hindered by host-specific controls and inefficient DNA amplification.
Innovation Solution
A method for rapidly generating nucleic acid constructs suitable for cell-free expression systems by installing regulatory and auxiliary components, including fusion elements, to produce a multiplex expression cassette that encodes a protein of interest with varying truncations and tags, allowing expression in diverse lysates without host-specific constraints.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cell-based expression systems are used, then host-specific regulatory control elements can be utilized, but the system becomes sensitive to toxic protein synthesis and requires complex host-matched regulatory elements
Solution Approach 1:
The patent extracts the regulatory control elements from the cellular host system and places them in a cell-free expression system. This allows the use of universal regulatory elements (T7 promoter, ribosome binding sites) that are not dependent on specific host organisms, thereby eliminating host-specific constraints while maintaining reliable protein expression.
Solution Approach 2:
The patent introduces a cell-free expression system as an intermediary between the nucleic acid template and protein production. This intermediary system provides the necessary regulatory control elements (promoters, ribosome binding sites) in a controlled environment that is independent of living host cells, resolving the contradiction between reliability and complexity.
2Ease of manufacture
If cell-free protein synthesis systems are used, then the system can be treated as a reagent and is amenable to in vitro experimentation, but many cellular expression regulatory control paradigms still apply and must be optimized
Solution Approach 1:
The patent creates a universal expression system that can accommodate multiple protein sequences and regulatory elements in a single cell-free platform. The system uses universal regulatory control elements (T7 promoter, conserved ribosome binding sites) that work across different protein expressions, thereby achieving both ease of manufacture and broad adaptability.
3Productivity
If membrane proteins are overexpressed in traditional systems, then protein yield increases, but aggregation and precipitation issues arise and purification becomes difficult
Solution Approach 1:
The patent employs solubility tags (such as GST, MBP, or maltose binding protein) that automatically bind to the membrane protein during expression, providing self-service solubility enhancement. This prevents aggregation and precipitation while maintaining high protein yield, as the solubility tag acts autonomously to keep the protein in solution without requiring additional purification steps.
4Productivity
If fusion partners are used to increase expression and promote membrane integration, then protein yield improves, but the identification of suitable fusion partners becomes trial and error and is not generalizable
Solution Approach 1:
The patent systematically varies parameters of the expression system (promoter strength, ribosome binding site sequences, solubility tag types, fusion partner sequences) to identify optimal conditions for membrane protein expression. By changing these parameters in a controlled manner within the cell-free system, the patent achieves high expression efficiency while making the process more reproducible and less trial-and-error oriented.
Data Source
AI summary
Provided herein are linear expression constructs and methods of cell-free protein synthesis, optimised cell-free protein synthesis (CFPS) reagents, and methods for optimising CFPS reagents to increase protein expression yields. The constructs and methods are applicable to protein expression on a microfluidic device having hydrophobic surfaces. The constructs are applicable for making membrane or other hydrophobic proteins have multiple solubility tags.